{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T20:32:35Z","timestamp":1722285155411},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,12]]},"DOI":"10.7759\/cureus.24954","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T04:39:32Z","timestamp":1652416772000},"source":"Crossref","is-referenced-by-count":1,"title":["Graves\u2019 Ophthalmopathy in the Setting of Primary Hypothyroidism"],"prefix":"10.7759","author":[{"given":"Sarah","family":"Alajmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aishah","family":"Ekhzaimy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0806317","article-title":"Clinical practice. Graves' ophthalmopathy","volume":"360","author":"Bartalena L","year":"2009","unstructured":"Bartalena L, Tanda ML. Clinical practice. Graves' ophthalmopathy. N Engl J Med. 2009, 360:994-1001. 10.1056\/NEJMcp0806317","journal-title":"N Engl J Med"},{"key":"ref2","article-title":"Typical graves' ophthalmopathy in primary hypothyroidism","volume":"67","author":"Kiran Z","year":"2017","unstructured":"Kiran Z, Rashid O, Islam N. Typical graves' ophthalmopathy in primary hypothyroidism. J Pak Med Assoc. 2017, 67:1104-6.","journal-title":"J Pak Med Assoc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.21.2.0393","article-title":"Management of Graves' ophthalmopathy: reality and perspectives","volume":"21","author":"Bartalena L","year":"2000","unstructured":"Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev. 2000, 21:168-99. 10.1210\/edrv.21.2.0393","journal-title":"Endocr Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.1200473","article-title":"Studies on the occurrence of ophthalmopathy in Graves' disease","volume":"120","author":"Marcocci C","year":"1989","unstructured":"Marcocci C, Bartalena L, Bogazzi F, Panicucci M, Pinchera A. Studies on the occurrence of ophthalmopathy in Graves' disease. Acta Endocrinol (Copenh). 1989, 120:473-8. 10.1530\/acta.0.1200473","journal-title":"Acta Endocrinol (Copenh)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.53.1518","article-title":"Graves' ophthalmopathy: epidemiology and natural history","volume":"53","author":"Hiromatsu Y","year":"2014","unstructured":"Hiromatsu Y, Eguchi H, Tani J, Kasaoka M, Teshima Y. Graves' ophthalmopathy: epidemiology and natural history. Intern Med. 2014, 53:353-60. 10.2169\/internalmedicine.53.1518","journal-title":"Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79573-8","article-title":"Has the target autoantigen for Graves' ophthalmopathy been found?","volume":"352","author":"McGregor AM","year":"1998","unstructured":"McGregor AM. Has the target autoantigen for Graves' ophthalmopathy been found?. Lancet. 1998, 352:595-6. 10.1016\/S0140-6736(05)79573-8","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.76.2.8094394","article-title":"Thyrotropin receptor antibodies in hypothyroid Graves' disease","volume":"76","author":"Kasagi K","year":"1993","unstructured":"Kasagi K, Hidaka A, Nakamura H, Takeuchi R, Misaki T, Iida Y, Konishi J. Thyrotropin receptor antibodies in hypothyroid Graves' disease. J Clin Endocrinol Metab. 1993, 76:504-8. 10.1210\/jcem.76.2.8094394","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.615993","article-title":"Epidemiology, natural history, risk factors, and prevention of Graves' orbitopathy","volume":"11","author":"Bartalena L","year":"2020","unstructured":"Bartalena L, Piantanida E, Gallo D, Lai A, Tanda ML. Epidemiology, natural history, risk factors, and prevention of Graves' orbitopathy. Front Endocrinol (Lausanne). 2020, 11:615993. 10.3389\/fendo.2020.615993","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy","volume":"185","author":"Bartalena L","year":"2021","unstructured":"Bartalena L, Kahaly GJ, Baldeschi L, et al.. The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy. Eur J Endocrinol. 2021, 185:G43-67. 10.1530\/EJE-21-0479","journal-title":"Eur J Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn RS","year":"2010","unstructured":"Bahn RS. Graves' ophthalmopathy. N Engl J Med. 2010, 362:726-38. 10.1056\/NEJMra0905750","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2000.10.1093","article-title":"Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels","volume":"10","author":"Khoo DH","year":"2000","unstructured":"Khoo DH, Eng PH, Ho SC, et al.. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels. Thyroid. 2000, 10:1093-100. 10.1089\/thy.2000.10.1093","journal-title":"Thyroid"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2011.186","article-title":"Hyperthyroid vs hypothyroid eye disease: the same severity and activity","volume":"25","author":"Kashkouli MB","year":"2011","unstructured":"Kashkouli MB, Pakdel F, Kiavash V, Heidari I, Heirati A, Jam S. Hyperthyroid vs hypothyroid eye disease: the same severity and activity. Eye (Lond). 2011, 25:1442-6. 10.1038\/eye.2011.186","journal-title":"Eye (Lond)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-030010","article-title":"Clinical review 157: pathophysiology of Graves' ophthalmopathy: the cycle of disease","volume":"88","author":"Bahn RS","year":"2003","unstructured":"Bahn RS. Clinical review 157: pathophysiology of Graves' ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab. 2003, 88:1939-46. 10.1210\/jc.2002-030010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/BF03348001","article-title":"Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects","volume":"20","author":"Takasu N","year":"1997","unstructured":"Takasu N, Oshiro C, Akamine H, et al.. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects. J Endocrinol Invest. 1997, 20:452-61. 10.1007\/BF03348001","journal-title":"J Endocrinol Invest"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202203260803","article-title":"Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis","volume":"326","author":"Takasu N","year":"1992","unstructured":"Takasu N, Yamada T, Takasu M, et al.. Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N Engl J Med. 1992, 326:513-8. 10.1056\/NEJM199202203260803","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/182176","article-title":"Changes of TSH-stimulation blocking antibody (TSBAb) and thyroid stimulating antibody (TSAb) over 10 years in 34 TSBAb-positive patients with hypothyroidism and in 98 TSAb-positive Graves' patients with hyperthyroidism: reevaluation of TSBAb and TSAb in TSH-receptor-antibody (TRAb)-positive patients","volume":"2012","author":"Takasu N","year":"2012","unstructured":"Takasu N, Matsushita M. Changes of TSH-stimulation blocking antibody (TSBAb) and thyroid stimulating antibody (TSAb) over 10 years in 34 TSBAb-positive patients with hypothyroidism and in 98 TSAb-positive Graves' patients with hyperthyroidism: reevaluation of TSBAb and TSAb in TSH-receptor-antibody (TRAb)-positive patients. J Thyroid Res. 2012, 2012:182176. 10.1155\/2012\/182176","journal-title":"J Thyroid Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6663.1574","article-title":"Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy","volume":"297","author":"Kendall-Taylor P","year":"1988","unstructured":"Kendall-Taylor P, Crombie AL, Stephenson AM, Hardwick M, Hall K. Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy. BMJ. 1988, 297:1574-8. 10.1136\/bmj.297.6663.1574","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2008.071704","article-title":"Infiltrative ophthalmopathy and primary hypothyroidism: a rare clinical manifestation of a common disease","volume":"85","author":"Rajput R","year":"2009","unstructured":"Rajput R, Dhingra A, Kumar K, Sen J. Infiltrative ophthalmopathy and primary hypothyroidism: a rare clinical manifestation of a common disease. Postgrad Med J. 2009, 85:40-2. 10.1136\/pgmj.2008.071704","journal-title":"Postgrad Med J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/93954-graves-ophthalmopathy-in-the-setting-of-primary-hypothyroidism","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:23Z","timestamp":1707507623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/93954-graves-ophthalmopathy-in-the-setting-of-primary-hypothyroidism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.24954","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,12]]}}}